Department of Urology, VA Medical Center and UCSF, San Francisco, California.
Research Institute, California Pacific Medical Center, San Francisco, California.
Mol Cancer Ther. 2017 Dec;16(12):2840-2848. doi: 10.1158/1535-7163.MCT-17-0400. Epub 2017 Aug 11.
miRNAs are implicated in regulating cancer progression and metastasis. Here, we show that miR-720 is positively associated with renal cell carcinoma (RCC). Elevated levels of miR-720 were observed in a panel of RCC cell lines and clinical tissues compared with nonmalignant cell line and normal samples. Loss of miR-720 function inhibited proliferation, migration, and invasion and induced apoptosis in RCC cell lines and repressed tumor growth in xenograft mouse models. Conversely, gain of miR-720 function in nonmalignant HK-2 cells induced procancerous characteristics. Silencing of miR-720 caused a marked induction in the levels of endogenous αE-catenin and E-cadherin protein levels in anti720 transfected cells compared with control, whereas miR-720 overexpression in RCC cell lines reduced activity of a luciferase reporter gene fused to the wild-type αE-catenin or E-cadherin 3'UTR compared with nonspecific 3'UTR control, indicating that αE-catenin-E-cadherin complex is a direct and functional target of miR-720 in RCC. We also observed attenuation of β-catenin, CD44, and Akt expression in RCC cells transfected with miR-720 inhibitor compared with control. Furthermore, miR-720 exhibited clinical significance in RCC. Expression of miR-720 significantly distinguished malignant from normal samples. Elevated miR-720 levels positively correlated with higher Fuhrman grade, pathologic stage, and poor overall survival of RCC patients. These findings uncover a new regulatory network in RCC involving metastasis-promoting miR-720 that directly targets expression of key metastasis-suppressing proteins E-cadherin and αE-catenin complex. These results suggest that therapeutic regulation of miR-720 may provide an opportunity to regulate EMT and metastasis in RCC. .
miRNAs 参与调控癌症的进展和转移。在这里,我们表明 miR-720 与肾细胞癌(RCC)呈正相关。与非恶性细胞系和正常样本相比,在一系列 RCC 细胞系和临床组织中观察到 miR-720 水平升高。miR-720 功能丧失抑制了 RCC 细胞系的增殖、迁移和侵袭,并诱导细胞凋亡,并在异种移植小鼠模型中抑制肿瘤生长。相反,在非恶性 HK-2 细胞中获得 miR-720 功能诱导了促癌特征。与对照相比,沉默 miR-720 导致转染细胞中内源性 αE-连环蛋白和 E-钙粘蛋白蛋白水平明显升高,而 miR-720 在 RCC 细胞系中的过表达与非特异性 3'UTR 对照相比,降低了与野生型 αE-连环蛋白或 E-钙粘蛋白 3'UTR 融合的荧光素酶报告基因的活性,表明 αE-连环蛋白-E-钙粘蛋白复合物是 miR-720 在 RCC 中的直接和功能靶标。我们还观察到与对照相比,用 miR-720 抑制剂转染的 RCC 细胞中 β-连环蛋白、CD44 和 Akt 的表达减弱。此外,miR-720 在 RCC 中具有临床意义。miR-720 的表达显著区分了恶性和正常样本。RCC 患者中 miR-720 水平升高与 Fuhrman 分级较高、病理分期较高和总体生存不良呈正相关。这些发现揭示了一个涉及促进转移的 miR-720 的新的 RCC 调控网络,该网络直接靶向关键转移抑制蛋白 E-钙粘蛋白和 αE-连环蛋白复合物的表达。这些结果表明,miR-720 的治疗调节可能为调节 EMT 和 RCC 中的转移提供机会。